BVS Bioventus

Bioventus to Report First Quarter of Fiscal Year 2025 Financial Results on May 6, 2025

Bioventus to Report First Quarter of Fiscal Year 2025 Financial Results on May 6, 2025

DURHAM, N.C., April 28, 2025 (GLOBE NEWSWIRE) -- , a global leader in innovations for active healing, today announced that it will report financial results for the first quarter of fiscal year 2025 before the market opens on Tuesday, May 6, 2025. The Company’s management will host a conference call at 8:30 a.m. Eastern Time that same day to discuss the results and provide a business update.

To participate in the conference call, dial 1-833-636-0497 and refer to the Bioventus Inc. Conference Call.

A live webcast of the call and accompanying materials will also be provided on the “Investor Relations” section of the Company's website at . The webcast will be archived at the same site and available for replay until May 5, 2026.

About Bioventus

Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations for Active Healing from Bioventus include offerings for Pain Treatments, Restorative Therapies and Surgical Solutions. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide. For more information, visit and follow the Company on and . Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC.

Investor and Media Inquiries:

Dave Crawford

919-474-6787



EN
28/04/2025

Underlying

BVSBioventus

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Bioventus

 PRESS RELEASE
Free
BVS BIOVENTUS

Bioventus Reports First Quarter Financial Results

Bioventus Reports First Quarter Financial Results Q1 reported revenue of $123.9 million declined 4.3%; Organic* revenue advanced 5.0%First quarter net loss was $0.04 per share compared to a loss of $0.08 in the prior-year periodNon-GAAP earnings* of $0.08 per share increased 33%Company reiterated revenue, Adjusted EBITDA* and Non-GAAP EPS* guidance for full year 2025 DURHAM, N.C., May 06, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or the "Company"), a global leader in innovations for active healing, today reported financial results for the three months ended Marc...

May 6, 2025 1 EN
 PRESS RELEASE
Free
BVS BIOVENTUS

Bioventus to Report First Quarter of Fiscal Year 2025 Financial Result...

Bioventus to Report First Quarter of Fiscal Year 2025 Financial Results on May 6, 2025 DURHAM, N.C., April 28, 2025 (GLOBE NEWSWIRE) -- , a global leader in innovations for active healing, today announced that it will report financial results for the first quarter of fiscal year 2025 before the market opens on Tuesday, May 6, 2025. The Company’s management will host a conference call at 8:30 a.m. Eastern Time that same day to discuss the results and provide a business update. To participate in the conference call, dial 1-833-636-0497 and refer to the Bioventus Inc. Conference Call. A li...

April 28, 2025 1 EN
 PRESS RELEASE
Free
BVS BIOVENTUS

Bioventus Announces Fourth Quarter and Full Year 2024 Financial Result...

Bioventus Announces Fourth Quarter and Full Year 2024 Financial Results Accelerated fourth quarter sales growth to 13.5%Fourth quarter gross margin expanded 310 bps and adjusted gross margin* expanded 230 bpsFourth quarter cash from operations of $19.3 million increased 86.3%Provides full-year 2025 financial guidance reflecting continued above market revenue growth and continued operating margin expansion DURHAM, N.C., March 11, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced fourth...

March 11, 2025 1 EN
 PRESS RELEASE
Free
BVS BIOVENTUS

Bioventus to Report Fourth Quarter of Fiscal Year 2024 Financial Resul...

Bioventus to Report Fourth Quarter of Fiscal Year 2024 Financial Results on March 11, 2025 DURHAM, N.C., Feb. 28, 2025 (GLOBE NEWSWIRE) -- a global leader in innovations for active healing, today announced that it will report financial results for the fourth quarter of fiscal year 2024 before the market opens on Tuesday, March 11, 2025. The Company’s management will host a conference call at 8:30 a.m. Eastern Time that same day to discuss the results and provide a business update. To participate in the conference call, dial 1-833-636-0497 and refer to the Bioventus Inc. Conference Call....

February 28, 2025 1 EN
 PRESS RELEASE
Free
BVS BIOVENTUS

Bioventus to Present at the 43rd Annual J.P. Morgan Healthcare Confere...

Bioventus to Present at the 43rd Annual J.P. Morgan Healthcare Conference DURHAM, N.C., Jan. 07, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Rob Claypoole, chief executive officer, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025, at 10:30 a.m. PT (1:30 p.m. ET). The live webcast of the presentation, including Q&A, may be accessed on the Investors section of the Bioventus website and will be available until February 15, 2025. About BioventusBioventus delivers clinical...

January 7, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch